{"id":"W1703213295","doi":"10.2147/dddt.s78036","title":"Spotlight on pembrolizumab in the treatment of advanced melanoma","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Melanoma; Metastatic melanoma; Food and drug administration; Immune system; Immunotherapy; Disease; Cancer; Drug; Immune checkpoint; Oncology; Immunology; Cancer research; Internal medicine; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005901558,0.0004805251,0.000905575,0.00152482,0.0002206888,0.0007190233,0.0006051427,0.000986974,0.004556014],"category_scores_gemma":[0.0006463009,0.0002103994,0.0004913723,0.001371902,0.0003294908,0.001428983,0.0005132914,0.002507998,0.001987336],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004390602,"about_ca_system_score_gemma":0.0006764518,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000736564,"about_ca_topic_score_gemma":0.001962675,"domain_scores_codex":[0.9998253,0.00003442154,0.00002334201,0.00002559988,0.00007433741,0.00001692907],"domain_scores_gemma":[0.9997221,0.0001195753,0.00003672441,0.000006784403,0.00007903972,0.00003581325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000914713,0.00006208684,0.00009741379,0.01045529,0.00007532711,0.0001645703,0.00005089111,0.0002311239,0.001838472,0.003519113,0.0651297,0.9182845],"study_design_scores_gemma":[0.00002218283,0.00008990047,0.0004692299,0.003131603,0.0000797472,0.00082757,0.00002780825,0.00007204188,0.000230877,0.001546758,0.9934919,0.00001035701],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008828957,0.9977261,0.00008356283,0.0007181243,0.0004237552,0.000003976221,0.00001483197,0.000006197624,0.0009351554],"genre_scores_gemma":[0.0005244992,0.9975693,0.000141065,0.0006215978,0.000386775,0.000003907034,0.00002362978,0.000001521776,0.0007276496],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004556014,"threshold_uncertainty_score":0.01524132,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08665092685978829,"score_gpt":0.3368170679676156,"score_spread":0.2501661411078273,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}